Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this randomized controlled trial is evaluate the out come of:
The main questions it aims to answer is:
This single blind parallel randomized controlled trial will be conducted on (30 patients in each group) presented to Alexandria University Hospitals with acute pulmonary edema defined as: acute onset of dyspnea < 6 hrs, tacchypnea ( respiratory rate ≥30 breaths/min), bilaterak crepitations, O2 saturation < 90% on room air with associted sympathetic surge recognized by presence of tacchycardia, agitationa and blood pressure ≥ 160/90 mmHg
All patients included in the study will be allocated randomly using computer software with concealment of randomization in to two groups:
Initial, peak rate within the first hour, duration of IV nitroglycerin infusion will be recorded in both groups.
Initial and maximum dose of loop diuretic will be recorded in both groups.
Outcome:
Patients will be followed during ED stay to compare the two groups as regard:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| High dose Nitroglycerin | Active Comparator | Initial dose of >100 mic/min will be initiated |
|
| Low dose Nitroglycerin | Active Comparator | Initial dose < 100 mic /min will be started |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nitroglycerin | Drug | high dose Nitroglycerin |
|
| Measure | Description | Time Frame |
|---|---|---|
| Resolution of symptoms | ( hypoxia, high blood pressure and tacchypnea ) | approximately 6 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
1 - Patients indicated for emergency endotracheal intubation. 2-Patients with history of nitroglycerin allergy. 3-Preload dependent patients as patients with aortic stenosis. 4-Drug interaction with nitroglycerin as sildenafil, ergots. 5-Patients indicated for emergency percutaneous intervention.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Abdelrahman Hemeda, Resident | Alexandria University, Faculty of Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Alexandria University, Faculty of Medicine | Alexandria | Egypt |
Not provided
| ID | Term |
|---|---|
| D011654 | Pulmonary Edema |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D005996 | Nitroglycerin |
| ID | Term |
|---|---|
| D009574 | Nitro Compounds |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided